Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 30:14:34.
doi: 10.4103/abr.abr_434_24. eCollection 2025.

Prevalence and Odds of Cognitive Impairment in Multiple Sclerosis Subtypes and Neuromyelitis Optica Spectrum Disorder: A Case-Control Study

Saeed Vaheb  1   2 , Ziba Rajaei  1 , Vahid Shaygannejad  2   3 , Omid Mirmosayyeb  2
Affiliations

Prevalence and Odds of Cognitive Impairment in Multiple Sclerosis Subtypes and Neuromyelitis Optica Spectrum Disorder: A Case-Control Study

Saeed Vaheb et al. Adv Biomed Res. .

Abstract

Background: Autoimmune demyelinating disorders, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD), are caused by persistent inflammation and damage to the central nervous system. Cognitive impairment (CI) is a growing challenge in these diseases, underscoring the need for a thorough exploration of its prevalence and risk across various subtypes. This study aimed to assess the prevalence and odds of CI using the Symbol Digit Modalities Test (SDMT) in various MS subtypes and NMOSD.

Materials and methods: A case-control study involving 616 participants, including healthy controls (HC) and individuals with different MS subtypes (Relapsing Remitting MS (RRMS), Secondary Progressive MS (SPMS), Primary Progressive MS (PPMS)), clinically isolated syndrome (CIS), and NMOSD, was conducted. CI was defined as SDMT z-scores 1.5 standard deviations below the HC average. The chi-square test was used to assess the risk of CI.

Results: The prevalence of CI varied across different groups: HC (10.7%), RRMS (33.8%), SPMS (71.3%), PPMS (62.8%), CIS (19.2%), and NMOSD (32.8%). Odds ratios (OR) for CI were significantly increased in RRMS (OR: 4.23, confidence interval (CI): 2.18-8.22, P < 0.001), SPMS (OR: 20.58, CI: 10.36-40.88, P < 0.001), PPMS (OR: 14.02, CI: 5.80-33.86, P < 0.001), and NMOSD (OR: 4.04, CI: 2.07-7.87, P < 0.001) compared to HC.

Conclusion: This study emphasizes a significantly increased risk of CI in MS subtypes and NMOSD compared to HC. Although no significant difference in CI risk was found between individuals with RRMS and NMOSD, those with progressive forms of MS exhibited notably higher risks of CI.

Keywords: Cognitive impairment; multiple sclerosis; neuromyelitis optica spectrum disorder; prevalence.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Lopez JA, Denkova M, Ramanathan S, Dale RC, Brilot F. Pathogenesis of autoimmune demyelination: From multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. Clin Transl Immunol. 2021;10:e1316. doi: 10.1002/cti2.1316. - PMC - PubMed
    1. Ben-Zacharia AB. Therapeutics for multiple sclerosis symptoms. Mt Sinai J Med. 2011;78:176–91. - PubMed
    1. Schapiro RT. Managing symptoms of multiple sclerosis. Neurol Clin. 2005;23:177–87. - PubMed
    1. Penner I-K. Cognition in multiple sclerosis. Neurodegener Dis Manag. 2017;7:19–21. - PubMed
    1. Amato MP, Portaccio E, Goretti B, Zipoli V, Hakiki B, Giannini M, et al. Cognitive impairment in early stages of multiple sclerosis. Neurol Sci. 2010;31:211–4. - PubMed

LinkOut - more resources